Caitlin Kontulis
Director Financiero/CFO en PHIO PHARMACEUTICALS CORP. .
Fortuna: 7 769 $ al 31/05/2024
Cargos activos de Caitlin Kontulis
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Director Administrativo | - | - |
| Director Financiero/CFO | - | - | |
| Secretario Corporativo | - | - |
Historial de carrera de Caitlin Kontulis
Antiguos cargos conocidos de Caitlin Kontulis.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 18/04/2011 | - |
Formación de Caitlin Kontulis.
| Bryant University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 1 |
| Chief Administrative Officer | 1 |
| Director of Finance/CFO | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Caitlin Kontulis
- Experiencia
